TRENTON, N.J. - The New Jersey Supreme Court on Aug. 9 ruled that some failure-to-warn claims and some breach of warranty claims involving the Cordis Cypher drug-coated coronary stent may survive federal preemption, a ruling that applies to 47 state court cases in which plaintiffs claim that they were injured or that family members died after being implanted with the now-withdrawn stent (Vonnie Cornett v. Johnson & Johnson, et al., No. A-88/89 September Term 2010 066671, N.J. Sup.; 2012 N.J. LEXIS 831).
Follow this link to view a complimentary copy of the complete Mealey's article.